Other studies have shown the anti-proliferative and anti-angiogenic effects of IFN-α on CSCs in hepatocellular carcinoma, and the benefit of combining IFN with other conventional therapies in different models [33]. Here, IFNA1 is linked to hepatocellular carcinoma.